Adipo Therapeutics
Indianapolis, US · Founded 2016 · Indiana LLC · 5 known investors
Find your way into Adipo Therapeutics
356 people in our graph share verified history with the Adipo Therapeutics team — schools, employers, funds. One of them is your warm intro.
Michael Marquezunlockedknows Keith Johns · together at UNC Kenan-Flagler Business School (overlapped)
×10knows the team · via UNC Kenan-Flagler Business School
knows the team · via University of South Carolina
Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.
Founders & leadership
KJ
Keith JohnsinChief Operating Officer (COO)Keith Johns is an executive officer at Adipo Therapeutics, a company developing investigational therapeutics for weight loss. He has prior experience in pharmaceutical marketing and business leadership.
KW
Karen WursterinChief Executive OfficerKaren Wurster is an executive at Adipo Therapeutics with over 25 years in pharmaceutical brand management and commercialization, including experience in product development, global brand strategy, and US market launches.
MD
Meng DengNamed on SEC filing
Board
MC
Michael ClaymanBoard director
Investors · 5
Also in the syndicate · 2
Purdue Research FoundationVisionTech Partners
Funding
SEC filings, press & company announcements$6M disclosed across 2 of 3 rounds · 2020–2024
- Undisclosed amountbridge funding roundJan 2024
Elevate Ventures, IU Ventures, Purdue Research Foundation, VisionTech Partners
Source ↗
▶$4.7MraisedDec 2024 · 20 investors · BiotechnologyRule 506(b)
▶$4.7MraisedDec 2024 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith JohnsExecutive Officer
- Karen WursterExecutive Officer, Director
- Meng DengDirector
- Michael ClaymanDirector
- Offering amount
- $14.7M
- Amount sold
- $4.7M
- Proceeds to insiders
- $219.1K
- First sale
- Nov 2024
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$1.3MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedSep 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Meng DengExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Aug 2020
- Incorporated
- Limited Liability Company, Indiana, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Adipopharma14 shared keywordsAdipoPharma is a biotech company developing therapies based on the endocrine biology of adipose tissue and targeted rare genetic disorders. Founded in 2022 (formerly ALMS Therapeutics), its work relates to metabolic diseases such as diabetes and obesity.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Adipo Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adipo Therapeutics do?
- Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.
- Who are Adipo Therapeutics's investors?
- Adipo Therapeutics's investors include Elevate Ventures, IU Ventures, Riverbend Capital.
- How much funding has Adipo Therapeutics raised?
- Adipo Therapeutics has disclosed $6M raised across 2 of its 3 known rounds.
- Where is Adipo Therapeutics headquartered?
- Adipo Therapeutics is headquartered in Indianapolis, US.